by Elena Iemma | May 17, 2021 | News
PROVIDENCE, RI, May 17, 2021 /PRNewswire/ — EpiVax, Inc. (“EpiVax”) announces the publication “Highly conserved, non-human-like, and cross-reactive SARS-CoV-2 T cell epitopes for COVID-19 vaccine design and validation” in NPJ Vaccines. This research identifies...
by Annie De Groot | Jun 28, 2019 | Events
Meeting of the Blue Ribbon Study Panel on Biodefense A Manhattan Project for Biodefense: Taking Biological Threats Off the Table Thursday, July 11th 9:00AM – 3:45PM 58 E. 68th Street New York, New York Join Dr. Lenny Moise (Scientific Director, Vaccine Research)...